Organisation › Details
3P Biopharmaceuticals S.L.
3P Biopharmaceuticals is a leading European CDMO specialized in the process development and GMP manufacturing of biologics and cell therapy products in mammalian, microbial and yeast expression systems. With a highly qualified team of experts, 3P supports its clients offering manufacturing related drug development solutions from initial research, through preclinical and clinical trials to commercialization. 3P was created and promoted by a group of shareholders and institutions with large expertise in the biotechnology and pharmaceutical sector. Thanks to their financial effort and full confidence, 3P has been able to consolidate its activity into the international market and has become a reference for the biotech sector. *
|Industry||contract manufacturing (biologicals)|
|Street||Poligono Mocholí C/ Mocholí 2|
|Address record changed: 2013-09-30|
|Basic data||Employees||n. a.|
|* Document for »About Section«: Neovacs S.A.. (11/23/16). "Press Release: Neovacs Signs Production Partnership with 3P Biopharmaceuticals, a Leading GMP Producer of Biological Drugs". Paris & Boston, MA.|
Record changed: 2017-04-03
More documents for Infarco (Group)
-  3P Biopharmaceuticals S.L.. (5/5/15). "Press Release: 3P Biopharmaceuticals Acquires a Mass Spectrometer"....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to email@example.com and simply fill the subject line with the word »MSC newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]